Did you know that new targeted therapies for myasthenia gravis (MG) offer a faster onset of action and improved tolerance in comparison to conventional treatments? 

Credit available for this activity expires: 14/7/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/993422?ecd=bdc_podcast_libsyn_mscpedu